These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 4976718)

  • 1. [Blood lactate dehydrogenase activity in newborns with hemolytic disease due to Rh and ABO-incompatibility].
    Dobronravov AV
    Vopr Okhr Materin Det; 1969 Jan; 14(1):33-8. PubMed ID: 4976718
    [No Abstract]   [Full Text] [Related]  

  • 2. [The activity of glucose-6-phosphate dehydrogenase and of transketolase in the erythrocytes in hemolytic disease of the newborn].
    Kovalev IuR
    Vopr Okhr Materin Det; 1968 Jan; 13(1):9-13. PubMed ID: 4976082
    [No Abstract]   [Full Text] [Related]  

  • 3. [Materno-fetal incompatibility in the ABO system as a factor of protection against hemolytic disease caused by Rh incompatibility].
    Mollica F
    Minerva Pediatr; 1967 Mar; 19(13):610-1. PubMed ID: 4963996
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the acetylcholinesterase activity of the erythrocytes in hemolytic disease of the newborn].
    Sirchia G; Ferrone S; Milani R; Masera G
    Haematol Lat; 1966; 9(3):215-20. PubMed ID: 4966138
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation of the kinetic characteristics of red blood cell acetylcholinesterase in ABO, Rh hemolytic disease of the newborn and thalassemia major cases.
    Ozand P; Artvinli S; Yarimağan S
    Turk J Pediatr; 1970; 12(1):1-7. PubMed ID: 4992911
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of erythrocytic and plasmatic neuraminic acid in newborn infants with Rh and ABO hemolytic disease].
    Ambrosioni G; Serritelli G
    Clin Pediatr (Bologna); 1968 Sep; 50(9):540-6. PubMed ID: 4973613
    [No Abstract]   [Full Text] [Related]  

  • 7. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus].
    Nersisian VM
    Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aspect of reticulocytes and erythroblasts studied by fluorescence microscopy in hemolytic disease of the newborn caused by autoantibodies and isoantibodies. II. Reticulocytes in hemolytic disease of the newborn caused by Rh and ABO incompatibility].
    Lombardo G; Infortuna M; Franchina A
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):2005-11. PubMed ID: 821502
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activity and isoenzyme composition of lactate dehydrogenase and malate dehydrogenase in the blood and erythrocytes of newborn children with hemolytic disease].
    Usatenko MS; Berlin GI
    Vopr Med Khim; 1979; 25(1):59-62. PubMed ID: 570758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic disease of the newborn caused by fetomaternal incompatibility].
    Escandé CA; Lorenzo y de Ibarreta J; Temesio N; Garófalo O; Pérez-Scremini A; Vila-Vidal P; Vilanova R
    Arch Pediatr Urug; 1965 Jul; 36(7):455-68. PubMed ID: 4954973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thin layer chromatography of the total lipids in hemolytic disease of the newborn (Rh and ABO). 1. Principal lipid fractions in the plasma and quantitative determination of lipemia].
    Salvioli GP; Allocca G; Ambrosioni G
    Clin Pediatr (Bologna); 1968 Oct; 50(10):645-53. PubMed ID: 4988028
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemolytic disease of the newborn with ABO incompatibities, its immediate and late sequelae].
    Frishman MM; Smirnova GD; Pavliuk GA
    Pediatr Akus Ginekol; 1976; (4):17-8. PubMed ID: 825817
    [No Abstract]   [Full Text] [Related]  

  • 13. [Present status of the prevention of hemolytic disease of the newborn due to Rh factors incompatibility].
    de Sousa JS
    Rev Port Pediatr Pueric; 1969; 32(3):70-6. PubMed ID: 4185738
    [No Abstract]   [Full Text] [Related]  

  • 14. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM; Lenarsky C; Oakes RC; Reiff MI
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications arising in hemolytic disease of newborn].
    Maskiewicz W; Ornat K; Ziemniak J
    Pediatr Pol; 1977 Mar; 52(3):293-8. PubMed ID: 403504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thin-layer chromatography of total lipids in hemolytic disease of the newborn (Rh and ABO). 3. Principal lipid fractions in the erythrocyte in toto in the erythrocytic stroma].
    Salvioli GP; Ambrosioni G; Allocca G
    Clin Pediatr (Bologna); 1968 Dec; 50(12):926-31. PubMed ID: 4979138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythrocyte sedimentation and clinical findings in newborn infants with hemolytic disease].
    Maszkiewicz W; Irzyńska D
    Pediatr Pol; 1977 May; 52(5):503-6. PubMed ID: 407544
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemolytic disease of the newborn caused by incompatibility between mother and child of Rh and ABO blood types].
    Ogawa T
    Kango; 1966 Jul; 18(7):31-4. PubMed ID: 4958717
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 20. [The dynamics of serum-free amino acid concentration in newborn infants with hemolytic disease].
    Egorova AI; Aksenova NM
    Vopr Okhr Materin Det; 1972 Jan; 17(1):87-8. PubMed ID: 4629897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.